合成和研究无形酸双向药物携带平台
Huan Hong1,2, Wentao Ma1,2, Yushuang Jiao1,2
1State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, Wuhan 430070, P. R. China.
Journal of materials chemistry. B
|May 30, 2025
概括
一种新型药物平台通过将阿托瓦斯塔丁直接输送到斑块上来向动脉样硬化. 这种响应pH的SR-A向系统可以提高药物释放和疗效,同时减少副作用.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 心血管研究研究心血管研究
背景情况:
- 动脉样硬化 (AS) 构成全球健康威胁,需要有针对性的药物输送系统.
- 阿斯病变的特点是温和的酸性环境和巨细胞过度表达拾尸体受体A类 (SR-A).
研究的目的:
- 开发和评估一个响应pH的,针对SR-A的药物加载平台,用于动脉样硬化治疗.
- 为了在体外评估阿托瓦斯塔丁 (AT) 载荷的DS-HEP/ACP@AT系统的抗动脉样硬化疗效.
主要方法:
- 通过共沉制造硫酸-氨酸/无形酸 (DS-HEP/ACP) 平台的制造.
- 对平台的特性进行表征,并对药物释放,细胞吸收和抗动脉样硬化作用进行体外评估.
- 评估DS-HEP/ACP@AT系统的抗炎和降脂能力.
主要成果:
- DS-HEP/ACP平台在酸性环境中证明了药物的控制释放,延长循环和pH响应的药物释放.
- 该平台显示了高效的,由巨细胞介导的SR-A受体细胞吸收.
- DS-HEP/ACP@AT系统在体外表现出优异的抗动脉样硬化作用,包括抗炎和降脂作用,优于单一治疗.
结论:
- 开发的DS-HEP/ACP@AT系统是一个有前途的双重向平台,用于精确的动脉样硬化药物输送和增强治疗疗效.
- 这种多功能平台通过将向药物输送与内在的斑块调节特性相结合,为治疗动脉样硬化提供了一种新的策略.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


